Albumin-Bound Paclitaxel

This is a special type of medicine called Abraxane. It's a liquid medicine that helps fight cancer. It works by attaching the drug to a protein called albumin, which helps it get into the body and reach the cancer cells more effectively. It's given through an IV line.

Brand names:Abraxane
Medication

What people taking Albumin-Bound Paclitaxel report

Every report comes from a Lived member, sent anonymously.

Have you tried Albumin-Bound Paclitaxel for Pancreatic Cancer?

NameHow it went

About Albumin-Bound Paclitaxel

What It's For

Albumin-bound paclitaxel, sold as Abraxane and also available as generic paclitaxel protein-bound, is an intravenous chemotherapy drug. It is approved in the US for three cancers. In metastatic breast cancer, it is used after earlier chemotherapy for advanced disease has stopped working, or when the cancer comes back within six months of chemotherapy given after surgery. In non-small cell lung cancer that is locally advanced or has spread, it is a first treatment, given with carboplatin (another chemotherapy drug), for people who cannot be cured with surgery or radiation. In pancreatic cancer that has spread, it is a first treatment given with gemcitabine, another chemotherapy drug. The active ingredient is the same paclitaxel found in older paclitaxel injection (once sold as Taxol), but the two products are made differently and have different doses and approved uses. The older form, for example, is used for ovarian cancer; the albumin-bound form is not approved for it. Oncologists sometimes use albumin-bound paclitaxel for other cancers, such as head and neck, esophageal, bladder, endometrial or cervical cancer, depending on the situation.

How It Works

Cancer cells divide over and over, and each division depends on microtubules, tiny protein scaffolds that pull copied chromosomes apart into the two new cells. Paclitaxel locks these scaffolds in place so they cannot take apart and rebuild as division requires. Cells that cannot complete division stop growing and die. Because healthy cells that divide quickly, such as those in bone marrow and hair follicles, are affected too, the drug also causes its typical side effects. Paclitaxel does not dissolve in water. The older form uses an oil-based solvent to carry it; in the albumin-bound form, the drug is attached to tiny particles of albumin, a protein from human blood. This solvent-free design lets it be given in a shorter infusion. In a large breast cancer trial it shrank tumors more often than the older form, although people did not live significantly longer on average.

Dosage & Administration

Albumin-bound paclitaxel is given by a nurse as an intravenous infusion in a clinic or hospital, usually over about 30 minutes. The dose is calculated from body size and the schedule depends on the cancer. For breast cancer it is commonly given once every three weeks. For lung cancer it is given weekly, with carboplatin added once every three weeks. For pancreatic cancer it is given weekly for three weeks, followed by a week off, with gemcitabine given right after it each time. Blood counts are checked before treatments, and doses are delayed or lowered when counts are too low or side effects such as nerve symptoms become significant. Lower starting doses are used for some people with liver problems. Pre-treatment allergy medicines may be considered for someone who has reacted to it before. This product cannot be swapped for other paclitaxel products, because the doses and instructions differ. It is reasonable to confirm that the right formulation is being given.

Side Effects

Hair loss, tiredness, nausea, diarrhea and muscle or joint aches are common. Many people also notice numbness, tingling or burning in the hands and feet (peripheral neuropathy). This nerve damage builds up with each dose, so it is worth reporting early and at every visit; pausing treatment or lowering the dose often lets it improve, sometimes over several weeks, though it does not always fully go away. Swelling of the ankles or legs, rash, mouth sores, vision changes and loss of appetite can also occur, particularly with the pancreatic cancer combination. The most serious risk, highlighted in a boxed warning, is a sharp drop in white blood cells called neutropenia, which weakens the body's defense against infection and can lead to sepsis, a life-threatening response to infection. A temperature of 100.4°F (38°C) or higher, chills, sore throat or other signs of infection need a call to the cancer care team right away. Platelets and red blood cells can also fall, causing easy bruising, bleeding or unusual fatigue. A sudden dry cough that does not go away or new shortness of breath can signal lung inflammation (pneumonitis) and also needs a call to the care team right away. Persistent vomiting or diarrhea, or signs of dehydration, should be reported promptly. Severe allergic reactions are uncommon; trouble breathing or swallowing, or swelling of the face, lips, tongue or throat, after leaving the clinic is an emergency, so call 911.

Interactions & Warnings

Albumin-bound paclitaxel is not given when the neutrophil count (the main infection-fighting white blood cell) is already low, or to anyone who has had a severe allergic reaction to it. People who have reacted to another taxane chemotherapy, such as solvent-based paclitaxel or docetaxel, can react to this one too, so that history matters. Liver problems raise drug levels and side effects; the dose may be reduced, and the drug is not recommended with severe liver impairment or, in pancreatic cancer, with moderate liver impairment. In pancreatic cancer, a blocked bile duct or a bile duct stent raises the risk of serious infection. The liver breaks paclitaxel down using two enzymes, CYP2C8 and CYP3A4. Medicines that strongly block or speed up these enzymes, including some antifungals, antibiotics, HIV medicines and seizure medicines, can change how much drug the body is exposed to. The care team should review every prescription, over-the-counter medicine and supplement. This drug can harm a developing baby. Women who could become pregnant should use effective birth control during treatment and for at least six months after the last dose, and men with a partner who could become pregnant should do so for at least three months after. It can also affect fertility, so anyone hoping to have children later may want to discuss options before starting. Breastfeeding is not advised during treatment or for two weeks after the last dose.

What to Expect

Treatment is given in repeating cycles and usually continues as long as the cancer is responding and side effects are manageable, with periodic scans to check whether tumors are shrinking, stable or growing. Infusion days typically include a blood test first, and some treatments may be postponed until counts recover. Nerve symptoms tend to appear later in treatment as doses add up. For most people taking it, the cancer has spread, and the goal is to control it, ease symptoms and extend life rather than cure it. In the main pancreatic cancer trial, adding albumin-bound paclitaxel to gemcitabine raised the share of people whose tumors shrank from 7% to 23% and extended median survival from about 6.7 to 8.5 months. Responses vary widely from person to person, and many people need dose changes or breaks along the way. If the cancer grows or side effects become too heavy, the oncologist will discuss other treatments.

Questions to Ask Your Doctor

  1. 1.What is the goal of this treatment for my cancer, and how does it compare with my other options?
  2. 2.How often will I get infusions, how will we know whether it is working, and how long might treatment last?
  3. 3.Who do I call, day or night, if I get a fever or feel unwell between treatments?
  4. 4.What should I do if I notice numbness or tingling, and what changes would we make to protect my nerves?
  5. 5.Are any of my current medicines, supplements or liver conditions a concern, and what should I know about fertility and birth control?

Last reviewed • Oct 2026

Educational content, not medical advice.